NFATc2 is a potential therapeutic target in human melanoma.
Perotti V, Baldassari P, Bersani I, Molla A, Vegetti C, Tassi E, Dal Col J, Dolcetti R, Anichini A, Mortarini R.
Perotti V, et al. Among authors: dal col j.
J Invest Dermatol. 2012 Nov;132(11):2652-60. doi: 10.1038/jid.2012.179. Epub 2012 Jun 21.
J Invest Dermatol. 2012.
PMID: 22718120
Free article.